{
  "completed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9
  ],
  "results": [
    {
      "example_idx": 0,
      "dataset_id": "1511",
      "question": "What is a lockdown?",
      "ground_truth_answer": "A lockdown is the implementation of strict restrictions and measures to limit people's movement and activities in order to control the spread of infections, such as the one mentioned in the given context.",
      "generated_response": "<think>\nOkay, the user is asking, \"What is a lockdown?\" Let me look at the provided context to find the answer. The context has four entries, all with the title \"Estimating the number of infections and the impact of non-\" and the passage \"Lockdown\" or \"banned Implemented with lockdown.57 24/3/2020\". \n\nHmm, the first three entries just repeat the title and the word \"Lockdown\" in the passage. The fourth one has a bit more: \"banned Implemented with lockdown.57 24/3/2020\". Maybe \"banned Implemented with lockdown\" is a typo or a misformatting. Perhaps it's supposed to be \"Implemented with lockdown banned\"? Or maybe \"banned\" is part of a different phrase.\n\nSince the user is asking for a definition of a lockdown, and the context doesn't provide a detailed explanation, I need to infer based on common knowledge. A lockdown typically refers to a strict set of restrictions imposed by authorities to prevent the spread of a disease, like during a pandemic. It involves closing non-essential businesses, schools, and public spaces, and limiting movement of people. \n\nBut the context here is minimal. The only relevant part is the mention of lockdown in relation to estimating infections and its impact. The date 24/3/2020 might refer to when a lockdown was implemented, possibly in a specific country. However, without more information, I can't confirm that. The user might be expecting a general definition since the context doesn't elaborate. \n\nI should check if there's any other information in the context that I'm missing. The repeated titles and passages don't add much. The fourth entry's \"banned Implemented with lockdown.57 24/3/2020\" is unclear. Maybe \"57\" is a page number or a reference. But again, without more context, it's hard to say. \n\nGiven that, the best approach is to provide a standard definition of a lockdown, as the provided context doesn't offer a detailed explanation. The user might be testing if I can use the context, but since the context is insufficient, I should rely on general knowledge while mentioning that the context doesn't provide a detailed definition.\n</think>\n\nA **lockdown** is a public health measure implemented by authorities to restrict movement and gatherings of people, typically during a pandemic",
      "retrieved_chunks": [
        "Title: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: banned Implemented with lockdown.57 24/3/2020"
      ],
      "computed_relevance": 0.0,
      "computed_utilization": 1.0,
      "computed_completeness": 0.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.2,
      "gt_completeness": 1.0,
      "gt_adherence": 0.0,
      "binary_pred": 0,
      "binary_gt": 0,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 1,
      "dataset_id": "1085",
      "question": "What complications are associated with CHIKV?",
      "ground_truth_answer": "Complications associated with CHIKV include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about the complications associated with CHIKV, which I know stands for Chikungunya virus. Let me look through the provided context to find the relevant information.\n\nFirst, in the passage, there's a list of complications from most common to least common. The sentence says: \"Other complications associated with CHIKV, from most common to least common, include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure.\" So that's a direct list. I need to make sure I include all of these in order.\n\nAdditionally, there's mention of specific cases in the La Reunion Island outbreaks where neonates contracted CHIKV through vertical transmission from mothers. The complications here include meningoencephalitis (also mentioned in the general list) and encephalitis. The context also notes that these neonatal infections can lead to severe outcomes like encephalitis and even fetal deaths in some cases. \n\nWait, the user is asking for complications associated with CHIKV in general. The main list provided in the first passage covers the major complications. The neonatal cases add specific complications related to vertical transmission, like neonatal infection, encephalitis, and fetal deaths. Should those be included as separate complications or part of the main list? The question is about complications associated with CHIKV, so both the general complications and those specific to transmission scenarios are relevant. \n\nSo the answer should include the ordered list from the first passage plus the neonatal complications mentioned in the other sections. Let me check again. The first passage lists respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure. Then, in the neonatal context, they mention encephalitis (which is part of central nervous system problems) and fetal deaths. Also, the study by Gerardin et al. mentions encephalitis due to vertical transmission. \n\nI need to present the main complications in order and then note the specific neonatal complications. The answer should be comprehensive but not redundant. Let me structure it as the ordered list first, then mention the neonatal transmission complications separately. That way, all complications are covered without repeating encephalitis if it's already in the main list.",
      "retrieved_chunks": [
        "The other group that is disproportionately affected by severe CHIKV is children. Other complications associated with CHIKV, from most common to least common, include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure . Title: Chikungunya: A Potentially Emerging Epidemic? Passage: and complications. Title: Chikungunya: A Potentially Emerging Epidemic?",
        "Title: Chikungunya: A Potentially Emerging Epidemic? Passage: More than 50% of patients who suffer from severe CHIKF are over 65 y old, and more than 33% of them die. Most adults who suffer from severe CHIKF have underlying medical conditions . The other group that is disproportionately affected by severe CHIKV is children. Other complications associated with CHIKV, from most common to least common, include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure .",
        "Passage: and complications. Title: Chikungunya: A Potentially Emerging Epidemic? Passage: During the 2005-2006 La Reunion Island outbreaks, Ramful et al. discovered that mothers could transmit CHIKV to their progeny during the perinatal period , and it is associated with a high degree of morbidity. By mean Day 4 of life, all of the neonates were symptomatic for CHIKV, exhibiting common CHIKF symptoms.",
        "discovered that mothers could transmit CHIKV to their progeny during the perinatal period , and it is associated with a high degree of morbidity. By mean Day 4 of life, all of the neonates were symptomatic for CHIKV, exhibiting common CHIKF symptoms. Six neonates were confirmed to have contracted CHIKV and developed mengoencephalitis. Of those mothers who, during the La Reunion Island epidemic, were infected long before delivery, only three fetal deaths were reported . Ramful et al.",
        "Title: Chikungunya: A Potentially Emerging Epidemic? Passage: A similar study by Gerardin et al. reported nineteen cases of neonatal infection associated with intrapartum maternal viremia that progressed to develop encephalitis owing to vertical transmission from infected mothers ."
      ],
      "computed_relevance": 0.21739130434782608,
      "computed_utilization": 0.21739130434782608,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.2,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 2,
      "dataset_id": "1248",
      "question": "What does Clade A contain?",
      "ground_truth_answer": "Clade A contains 1,889 viruses from 34 countries collected from 2010 to the present.",
      "generated_response": "<think>\nOkay, let's try to figure out what Clade A contains based on the provided context. The user is asking about \"Clade A,\" but looking through the passages, I notice that the clades mentioned are labeled with numbers and letters like 1A, 1B, 1C, and their subclades (e.g., 1A.1, 1B.1.1). There's no mention of a \"Clade A\" specifically. Instead, the main lineages discussed are 1A, 1B, and 1C, each with their own subclades.\n\nThe passages talk about how each clade has an APD (Average Pairwise Distance) of more than 7% from other clades and less than 7% within the clade. Exceptions are noted for certain subclades like 1B.1, 1B.2, 1A.1, and 1A.1.1. The 1A lineage is mentioned as containing 1,889 viruses from 34 countries, and it's divided into three second-order divisions. The 1B lineage includes human seasonal viruses, and 1C is related to swine viruses in China, South Korea, Europe, and Asia.\n\nSince the question refers to \"Clade A,\" but the context uses numerical prefixes like 1A, it's possible there's a misunderstanding or a typo. The correct lineages are 1A, 1B, 1C. If \"Clade A\" is meant to refer to 1A, then it would contain the viruses described under the 1A lineage. However, the answer should clarify that \"Clade A\" isn't explicitly mentioned and that the closest is 1A, which includes viruses from multiple countries, divided into subclades with specific APD criteria. The answer should note the absence of Clade A and suggest possible intended references to 1A or other lineages.\n</think>\n\nThe provided context does not explicitly mention a \"Clade A.\" Instead, the text refers to clades labeled with numerical prefixes (e.g., **1A**, **1B**, **1C**) and their subclades (e.g., 1A.1, 1B.1.1). For example:  \n- **Clade 1A** includes 1,889 viruses from 3",
      "retrieved_chunks": [
        "For the most part, each clade had an APD of \u03fe7% from other clades and almost all had an APD of \u03fd7% within the clade. The within-clade exceptions were the 1B.1 and 1B.2 clades . The 1B.1 second-order clade had too few representative sequences to calculate genetic distance, and 1B.2 represented multiple monophyletic clades that individually did not meet our criteria for further division. Similarly, the extensive 1B.1.1 clade did not meet criteria for further splitting. The exception to the between-clade threshold was associated with clades\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: were placed into seven clades.",
        "Each clade had an APD of \u03fe7% from other clades and an APD of \u03fd7% within the clade, although some minor exceptions were made when all other clade-defining criteria were met and mitigating circumstances supported the exception. Within-clade exceptions were made for the first-order 1A.1 and the extensive 1A.1.1 second-order clade\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: Clade designations for 1C swine lineage. The 1C lineage consisted of 315 viruses from 14 countries collected from 2010 to the present in China and South Korea. Avian H1 HA sequences were generally restricted to two monophyletic clades distinct from, but sister to, the 1C swine viruses: these HA sequences were defined as \"Other-Avian.\" The within-and between-clade APDs are presented in Table 4 . For the most part, each clade had an APD of \u03fe7% from other clades and an APD of \u03fd7% within the clade.",
        "Similarly, the extensive 1B.1.1 clade did not meet criteria for further splitting. The exception to the between-clade threshold was associated with clades\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: were placed into seven clades. The numerically dominant clades reflected intensive surveillance in the United States , investigator sequencing efforts in Canada , and the rapid dissemination of the 2009 H1N1 pandemic virus across global swine populations . Similarly, coordinated surveillance in Europe and Asia captured two primary clades of 1C Eurasian avian lineage currently circulating in the two continents.",
        "Title: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: Clade designations for 1A swine lineage. The 1A lineage contained 1,889 viruses from 34 countries collected from 2010 to the present . According to our nomenclature rules, we refined the classification of 1A viruses into three second-order divisions, each of which corresponds to earlier, regional classifica- Table 2 . Each clade had an APD of \u03fe7% from other clades and an APD of \u03fd7% within the clade, although some minor exceptions were made when all other clade-defining criteria were met and mitigating circumstances supported the exception. Within-clade exceptions were made for the first-order 1A.1 and the extensive 1A.1.1 second-order clade\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: Clade designations for 1C swine lineage.",
        "Avian H1 HA sequences were generally restricted to two monophyletic clades distinct from, but sister to, the 1C swine viruses: these HA sequences were defined as \"Other-Avian.\" The within-and between-clade APDs are presented in Table 4 . For the most part, each clade had an APD of \u03fe7% from other clades and an APD of \u03fd7% within the clade. The one within-clade exception in this lineage was 1C.2 , which had multiple monophyletic\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: The 1B human seasonal lineage within-and between-clade APDs are presented in Table 3 . For the most part, each clade had an APD of \u03fe7% from other clades and almost all had an APD of \u03fd7% within the clade. The within-clade exceptions were the 1B.1 and 1B.2 clades ."
      ],
      "computed_relevance": 0.20833333333333334,
      "computed_utilization": 0.20833333333333334,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 1.0,
      "gt_utilization": 0.041666666666666664,
      "gt_completeness": 0.041666666666666664,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 3,
      "dataset_id": "1696",
      "question": "How do the S1 subunits compare with that of SARS-likeCOV and human SARS-COV?",
      "ground_truth_answer": "The S1 subunit of 2019-nCoV shares around 70% identity with those of two bat SARS-like CoVs and human SARS-CoV.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how the S1 subunits of 2019-nCoV compare to those of SARS-like CoVs and human SARS-CoV. \n\nFirst, I need to look through the provided context for relevant information. The passages mention that the S1 subunit of 2019-nCoV shares around 70% identity with the two bat SARS-like CoVs and human SARS-CoV. Also, the core domain of the RBD (receptor-binding domain) is highly conserved. However, most of the amino acid differences in the RBD are in the external subdomain, which interacts directly with the host receptor. The external subdomain of 2019-nCoV's RBD has only 40% amino acid identity with other SARS-related coronaviruses.\n\nSo, putting this together: the S1 subunit has 70% identity with SARS-like and human SARS-CoV, but the RBD's external part is more variable. The core is conserved, but the external part is different, which might affect receptor interaction and transmission. The answer should highlight the 70% identity and the differences in the RBD's external subdomain.\n</think>\n\nThe S1 subunit of 2019-nCoV shares **around 70% identity** with the S1 subunits of bat SARS-like coronaviruses and human SARS-CoV. However, while the **core domain of the receptor-binding domain (RBD)** in the S1 subunit is highly conserved, most amino acid differences are localized to the **external subdomain** of the RBD, which is responsible for direct interaction with the host receptor. This external subdomain of 2019-nCoV's RBD exhibits only **40% amino acid identity** with other SARS-related coronaviruses, indicating significant divergence in regions critical for receptor binding and interspecies transmission.",
      "retrieved_chunks": [
        "The SL1, SL2, SL3, SL4, S5, SL5A, SL5B, and SL5C structures were similar among the 2019-nCoV, human SARS-CoV and the bat SARS-related ZC45. In the 2019-nCoV, part of the S5 found was inside Figure 7 Continued the orf1a/b , which was similar to SARS-CoV. In bat SARS-related CoV ZC45, the S5 was not found inside orf1a/b. The 2019-nCoV had the same SL6, SL7, and SL8 as SARS-CoV, and an additional",
        "Title: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: Spike glycoprotein comprised of S1 and S2 subunits. The S1 subunit contains a signal peptide, followed by an N-terminal domain and receptor-binding domain , while the S2 subunit contains conserved fusion peptide , heptad repeat 1 and 2, transmembrane domain , and cytoplasmic domain . We found that the S2 subunit of 2019-nCoV is highly conserved and shares 99% identity with those of the two bat SARS-like CoVs and human SARS-CoV . Thus the broad spectrum antiviral peptides against S2 would be an important preventive and treatment modality for testing in animal models before clinical trials . Though the S1\n\nTitle: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: subunit of 2019-nCoV shares around 70% identity to that of the two bat SARS-like CoVs and human SARS-CoV ), the core domain of RBD are highly conserved ).",
        "Learning from the roles of civet in SARS and camel in MERS, hunting for the animal source of 2019-nCoV and its more ancestral virus would be important for understanding the origin and evolution of this novel lineage B betacoronavirus. These findings provide the basis for\n\nTitle: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: As shown in Figure 7 , the SARS-CoV 5 \u2032 -UTR contains SL1, SL2, SL3, SL4, S5, SL5A, SL5B, SL5C, SL6, SL7, and SL8. The SL3 contains trans-cis motif . The SL1, SL2, SL3, SL4, S5, SL5A, SL5B, and SL5C structures were similar among the 2019-nCoV, human SARS-CoV and the bat SARS-related ZC45. In the 2019-nCoV, part of the S5 found was inside Figure 7 Continued the orf1a/b , which was similar to SARS-CoV.",
        "Thus the broad spectrum antiviral peptides against S2 would be an important preventive and treatment modality for testing in animal models before clinical trials . Though the S1\n\nTitle: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: subunit of 2019-nCoV shares around 70% identity to that of the two bat SARS-like CoVs and human SARS-CoV ), the core domain of RBD are highly conserved ). Most of the amino acid differences of RBD are located in the external subdomain, which is responsible for the direct interaction with the host receptor. Further investigation of this soluble variable external subdomain region will reveal its receptor usage, interspecies transmission and pathogenesis. Unlike 2019-nCoV and human SARS-CoV, most known bat SARSr-CoVs have two stretches of deletions in the spike receptor binding domain when compared with that of human SARS-CoV.",
        "However, the external subdomain of Spike\u2019s receptor binding domain of 2019-nCoV shares only 40% amino acid identity with other SARS-related coronaviruses. Remarkably, its orf3b encodes a completely novel short protein. Furthermore, its new orf8 likely encodes a secreted protein with an alpha-helix, following with a beta-sheet containing six strands. Learning from the roles of civet in SARS and camel in MERS, hunting for the animal source of 2019-nCoV and its more ancestral virus would be important for understanding the origin and evolution of this novel lineage B betacoronavirus. These findings provide the basis for\n\nTitle: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: As shown in Figure 7 , the SARS-CoV 5 \u2032 -UTR contains SL1, SL2, SL3, SL4, S5, SL5A, SL5B, SL5C, SL6, SL7, and SL8."
      ],
      "computed_relevance": 0.125,
      "computed_utilization": 0.125,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.12,
      "gt_utilization": 0.04,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 4,
      "dataset_id": "669",
      "question": "What is Bacillus subtilis?",
      "ground_truth_answer": "Bacillus subtilis is a species of bacteria that has been shown to be effective in the prevention and/or treatment of intestinal diseases such as diarrhea, colitis, irritable bowel syndrome, irritable bowel disease, and colorectal cancer. It is also a part of the normal intestinal microbiome and has been found in the healthy human gastrointestinal tract. Bacillus subtilis produces surfactins, fengycins, and iturins, which have antimicrobial and antiviral properties.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking, \"What is Bacillus subtilis?\" and they want an answer based on the provided context. Let me go through the passages again to gather all the relevant information.\n\nFirst, looking at the titles and passages, the main focus is on the secretome of intestinal bacilli, particularly Bacillus species. The context mentions that Bacillus subtilis is part of the healthy human gut microbiome, more colonizing than transient. They produce various lipopeptides like surfactins, fengycins, and iturins. Surfactins are less abundant but have broad antimicrobial and antiviral activities. They also protect against extracellular antibiotic vesicles from other species and modulate inflammation by affecting cytokines.\n\nAnother part says that B. subtilis helps in restoring gut microflora balance by increasing beneficial species (Bifidobacterium, Lactobacillus, etc.) and decreasing harmful ones (Acinetobacter, Ruminococcus, etc.). It also retains gut barrier integrity, reduces endotoxins, and lessens inflammation. There's mention of its use in probiotics and traditional fermented foods, and that it's part of commercial probiotics like Enterogermina and Biosubtyl. Historically, Bacillus species weren't considered part of the normal intestinal microbiome, but recent studies show they are present in higher amounts than just from food ingestion.\n\nSo putting this together, Bacillus subtilis is a probiotic bacterium found in the human gut, known for producing antimicrobial substances, modulating the immune response, and maintaining gut health. It's used in probiotics and has therapeutic effects on intestinal diseases. The answer should include its role in the gut, the substances it produces, its effects on gut flora and inflammation, and its use in probiotics.\n</think>\n\n**Answer:**  \n*Bacillus subtilis* is a probiotic bacterium naturally present in the healthy human gastrointestinal tract (GIT), where it is well-adapted and colonizes rather than merely passing through transiently. It produces bioactive lipopeptides such as surfactins, fengycins, and iturins, which exhibit antimicrobial, antiviral, and anti-inflammatory properties. These compounds help protect against pathogens, modulate immune responses (e.g., reducing pro-inflammatory cytokines and increasing anti-inflammatory ones), and maintain gut barrier integrity. *",
      "retrieved_chunks": [
        "have been isolated from the healthy human GIT, where they are well-adapted and are more colonizing than transient . In environment, the vegetative forms of Bacillus are present usually near decomposing plants and in their\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: B. subtilis produces surfactins, fengycins and iturins in a ratio of 6:37:57 . The less abundant surfactins unlike other types of Bacillus lipopeptides exhibit a broad range of antimicrobial activities and possess antiviral action . They protect bacilli against extracellular antibiotic-containing vesicles of other species and inhibit phospholipase A2 resulting in subsequent downregulation of pro-inflammatory cytokines and upregulation of anti-inflammatory cytokines .",
        "were increased, while gut damage-promoting species of Acinetobacter sp., Ruminococcus sp., Clostridium spp., and Veillonella sp. were decreased . B. subtilis also retained gut barrier integrity, decreased the endotoxin concentration and reduced gut inflammation Bene et al., 2017) . Sporulation of B.",
        "Title: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: The efficacy of Lactobacillus and Bacillus in the prevention and/or treatment of intestinal diseases such as diarrhea, colitis, irritable bowel syndrome, irritable bowel disease, and colorectal cancer was demonstrated . In particular, treatment of colorectal colitis in mice with probiotic B. subtilis restored balance in gut microflora: beneficial species of Bifidobacterium, Lactobacillus, and Butyricicoccus spp. were increased, while gut damage-promoting species of Acinetobacter sp., Ruminococcus sp., Clostridium spp., and Veillonella sp. were decreased .",
        "as soil microorganisms were considered transient. Recent studies show that they are present in the GIT in the amounts significantly higher than what can be explained by their ingestion with food only. Bacillus spp. have been isolated from the healthy human GIT, where they are well-adapted and are more colonizing than transient . In environment, the vegetative forms of Bacillus are present usually near decomposing plants and in their\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: B.",
        "subtilis also retained gut barrier integrity, decreased the endotoxin concentration and reduced gut inflammation Bene et al., 2017) . Sporulation of B. subtilis plays a\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: Historically, species of Lactobacillus and Bacillus are found in the traditional fermented food products possessing beneficial properties for the intestinal function and are widely used as components of commercially available probiotics: DE111 , Enterogermina , Biosubtyl , Biosporin , BioSpora , Blicheni and Zhengchangsheng , GanedenBC 30 , Lactobacterin , HOWARU or DR20 , Yakult , PCC . In food industry, lactobacilli are applied as starter cultures in the production of fermented milk products, cheese, sausages, bread, kimchi, pickles, and yogurts, the latter accounting for the largest share of sales . The administration of probiotics has been shown to favorably\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: For a long time, the representatives of Bacillus genus, unlike the species of Lactobacillus, were not considered as a part of the normal intestinal microbiome."
      ],
      "computed_relevance": 0.2,
      "computed_utilization": 0.68,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.4090909090909091,
      "gt_utilization": 0.18181818181818182,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 0.0,
      "binary_pred": 1,
      "binary_gt": 0,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 5,
      "dataset_id": "81",
      "question": "What past research has been done on severe, single-wave pandemics?",
      "ground_truth_answer": "The given passages do not specifically mention past research on severe, single-wave pandemics. However, they do reference research on pandemic strains, influenza spread, and pandemic severity categories, as well as the origins and circulation of specific pandemic influenza strains.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about past research on severe, single-wave pandemics. First, I need to look through the provided contexts to find any mentions of such research.\n\nLooking at the first context from Hong Kong's research response, they mention studies on the 2009 pH1N1 pandemic. They talk about confirming the origins of the strain using a local swine influenza surveillance program and pathogenesis studies. But the 2009 pandemic had multiple waves, so that might not fit the \"single-wave\" part.\n\nNext, the title \"The origins of the great pandemic\" refers to the 1889 pandemic, which had three major waves. The passage discusses the 1889 pandemic's waves and possible connections to the 1918 pandemic. However, the 1889 one wasn't a single wave, so that's not relevant here.\n\nThe third title is about an economic analysis considering five pandemic severity categories. It mentions the 2009 pandemic data for health outcomes but doesn't specify single-wave pandemics.\n\nThe fourth context, \"On Temporal Patterns...\" in Taiwan, uses a Richards model for multi-wave epidemics. They mention distinguishing between waves, but again, it's about multi-wave scenarios.\n\nWait, the user is asking about severe, single-wave pandemics. The contexts provided don't explicitly mention any single-wave pandemics. The 1889 and 2009 pandemics both had multiple waves. The Hong Kong context talks about the 2009 pandemic's research but not about single-wave. The economic study uses 2009 data but doesn't specify wave count. The Richards model is for multi-wave. The origins study mentions the 1889 and 1918 pandemics, which had multiple waves too.\n\nHmm, maybe there's a trick here. The user might be expecting an answer based on the given contexts, but if none of them discuss single-wave pandemics, then the answer would be that the research mentioned doesn't cover single-wave cases. Alternatively, perhaps the 1918 pandemic's herald waves are considered, but the passage is speculative and doesn't confirm a single wave. The 1918 pandemic itself had multiple waves.\n\nSo, based on the provided contexts, there's no direct mention of research on severe, single-wave pandemics. The studies referenced deal",
      "retrieved_chunks": [
        "56 While we focused on research into the epidemiology, impact, and control of pH1N1, much important research on pH1N1 has been carried out in other areas outside the scope of our review. To give two specific examples, local researchers confirmed the origins of the 2009 pandemic strain by comparison with a detailed local swine influenza surveillance program, 65 and performed important basic studies on pathogenesis. 66 Two sets of studies\n\nTitle: Economic analysis of pandemic influenza mitigation strategies for five pandemic severity categories\nPassage: Several related studies which also used individualbased simulation models of influenza spread coupled with costing models are those of those of Sander et al., Perlroth et al., Brown et al., and Andradottir et al. . The current study extends upon the scope of these studies in several ways: five gradations of pandemic severity are considered, more combinations of interventions are considered, social distancing interventions of varying durations are considered, and probabilities of severe health outcomes for each severity category are based on fatality, hospitalization and ICU usage data as observed from the 2009 pandemic.",
        ". The current study extends upon the scope of these studies in several ways: five gradations of pandemic severity are considered, more combinations of interventions are considered, social distancing interventions of varying durations are considered, and probabilities of severe health outcomes for each severity category are based on fatality, hospitalization and ICU usage data as observed from the 2009 pandemic. Also in contrast with those models,\n\nTitle: On Temporal Patterns and Circulation of Influenza Virus Strains in Taiwan, 2008-2014: Implications of 2009 pH1N1 Pandemic\nPassage: When there is more than one wave of infections, as in our current study, a variation of the Richards model can be utilized, which makes the distinction between two types of turning points ; one type which occurs at the peak incidence, and a second type which occurs in a multi-wave epidemic when the growth rate of the cumulative case number begins to increase again, indicating the beginning of the next wave.",
        "Title: The origins of the great pandemic\nPassage: Because the 1889 pandemic unfolded with three major waves worldwide from 1889 to 1892 , with the 1892 wave being the most intense, at least on the East Coast of the USA, it seems worth considering whether so-called herald waves of the 1918 pandemic might have stretched back all the way to 1915. Viruses with identical or nearly identical genome sequences to those in the fall wave were circulating in early 1918 , at a time prior to the recognition of a new pandemic. It is perhaps not so great a leap to imagine that these viruses were related to\n\nTitle: The epidemiological and public health research response to 2009 pandemic influenza A(H1N1): experiences from Hong Kong\nPassage: of convalescent plasma to treat severe infections was shown to be feasible in a pandemic 57 and evidence of its effectiveness albeit from a small study should justify further studies. 56 While we focused on research into the epidemiology, impact, and control of pH1N1, much important research on pH1N1 has been carried out in other areas outside the scope of our review. To give two specific examples, local researchers confirmed the origins of the 2009 pandemic strain by comparison with a detailed local swine influenza surveillance program, 65 and performed important basic studies on pathogenesis."
      ],
      "computed_relevance": 0.38461538461538464,
      "computed_utilization": 0.7692307692307693,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.26666666666666666,
      "gt_utilization": 0.26666666666666666,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 6,
      "dataset_id": "1564",
      "question": "How many reported viral pneumonia?",
      "ground_truth_answer": "The passage does not provide a specific number of reported viral pneumonia cases overall. However, it mentions 2744 confirmed cases of pneumonia with 2019-nCoV infection in China, and it also mentions 77 fatal cases of pandemic H1N1v 2009 infection.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking \"How many reported viral pneumonia?\" based on the provided context. Let me go through each of the passages to see if there's a number mentioned.\n\nFirst, the first context is about the 2019-nCoV (now known as COVID-19) and mentions 2744 confirmed cases of pneumonia with 2019-nCoV infection. That's a specific number related to viral pneumonia caused by that virus.\n\nThen there are several passages about influenza viral pneumonia. The second and third contexts discuss bacterial co-infections in H1N1 cases, mentioning 77 fatal cases. But those are about bacterial co-infections, not the total number of viral pneumonia cases. The fourth and fifth contexts talk about attack rates for influenza, like 29% and 61% in different age groups, but those are percentages, not actual numbers of cases. The last context mentions patients with pneumonia more likely to receive antiviral therapy but again no specific numbers.\n\nThe user is asking for the number of reported viral pneumonia cases. The only specific number given is the 2744 confirmed cases of 2019-nCoV infected pneumonia from the first context. The other contexts don't provide a specific number of cases but discuss rates and percentages related to influenza. Since the question is about \"reported viral pneumonia,\" and the first context is the only one with a specific number, the answer should be 2744. I need to check if there's any other number I missed. The other contexts don't mention a total number of viral pneumonia cases, just statistics about influenza attack rates or co-infections. So the answer is 2744.\n</think>\n\nThe context provided mentions that as of 24:00 on 26 January 2020, there were **2,744 confirmed cases of pneumonia with 2019-nCoV infection** in China. This figure represents the reported cases of viral pneumonia specifically caused by the 2019-nCoV virus. Other passages discuss influenza-related viral pneumonia but do not provide a specific numerical count of cases. \n\n**Answer:** 2,744.",
      "retrieved_chunks": [
        "Title: A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)\nPassage: At 24:00 on 26 January 2020, the National Health Commission of the People's Republic of China has recorded a total of 2744 confirmed cases of pneumonia with 2019-nCoV infection from 30 provinces , including 461 severe cases and 80 deaths. A total of 51 cases have been cured and discharged. At present, 5794 suspected cases were recorded, 32,799 with close contacts to the confirmed patients have been tracked, 583 people were released from medical observation that day, and 30,453 people were still undergoing medical observation. A total of confirmed cases were reported from Hong Kong, Macao and Taiwan of China:\n\nTitle: Clinical review: Primary influenza viral pneumonia\nPassage: Bacterial co-infection, though uncommonly reported in the early stages of the 2009 H1N1 pandemic, may be more prevalent than initially thought. A recent analysis of lung specimens from 77 fatal cases of pandemic H1N1v 2009 infection found a prevalence of concurrent bacterial pneumonia in 29% of these patients .",
        "A total of confirmed cases were reported from Hong Kong, Macao and Taiwan of China:\n\nTitle: Clinical review: Primary influenza viral pneumonia\nPassage: Bacterial co-infection, though uncommonly reported in the early stages of the 2009 H1N1 pandemic, may be more prevalent than initially thought. A recent analysis of lung specimens from 77 fatal cases of pandemic H1N1v 2009 infection found a prevalence of concurrent bacterial pneumonia in 29% of these patients . The most common coinfecting bacterial pathogens were pneumococcus, Staphylococcus aureus, and Streptococcus pyogenes, with a median duration of illness of 6 days . Title: Clinical review: Primary influenza viral pneumonia\nPassage: age versus 6% to 9% of the adults 18 to 64 years of age and none of the children . Influenza attack rates during seasonal epidemics vary between 10% and 20% but can be much higher during pandemics.",
        "Title: Clinical review: Primary influenza viral pneumonia\nPassage: age versus 6% to 9% of the adults 18 to 64 years of age and none of the children . Influenza attack rates during seasonal epidemics vary between 10% and 20% but can be much higher during pandemics. For example, an analysis of the pandemic 2009 H1N1 influenza A outbreak in La Gloria, Veracruz, found clinical attack rates of 29% in adults older than 15 years and 61% in children younger than 15 years of age . However, these rates may be different in geographic areas of low population density. Title: Pneumonia among adults hospitalized with laboratory-confirmed seasonal influenza virus infection\u2014United States, 2005\u20132008\nPassage: Patients with pneumonia ] were significantly more likely to receive influenza antiviral therapy than patients without pneumonia ; P <0.01]."
      ],
      "computed_relevance": 0.06666666666666667,
      "computed_utilization": 0.06666666666666667,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.125,
      "gt_utilization": 0.125,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 7,
      "dataset_id": "1247",
      "question": "How has most of the analysis of MERS-CoV genetics  been performed?",
      "ground_truth_answer": "Most of the analysis of MERS-CoV genetics has been performed using high throughput or \"deep\" sequencing methods for complete genome deduction.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how most of the analysis of MERS-CoV genetics has been performed. I need to look through the provided context to find the relevant information.\n\nLooking at the first passage under the title \"MERS coronavirus: diagnostics, epidemiology and transmission,\" the first sentence says, \"Most of the analysis of MERS-CoV genetics has been performed using high throughput or 'deep' sequencing methods for complete genome deduction.\" That seems directly answering the question. \n\nI should check if there's any other mention of methods used. The same passage mentions that subgenomic sequencing, once the mainstay, has been less often published during MERS-CoV studies. But the primary method highlighted here is high throughput or deep sequencing. \n\nOther passages talk about genetic recombination, spike protein variations, and whole genome sequencing, but the key method for the analysis is the deep sequencing. The answer should focus on that. Let me make sure there's no conflicting information elsewhere. The other passages don't contradict this; they just add more details about specific findings. \n\nSo the answer is that most analysis has been done using high throughput or deep sequencing methods for complete genome deduction. I need to present this clearly and concisely, using the exact terms from the context.\n</think>\n\nMost of the analysis of MERS-CoV genetics has been performed using **high throughput or \"deep\" sequencing methods for complete genome deduction**. This approach has enabled comprehensive genomic studies of MERS-CoV, including tracking its travel, variation, and identifying genetic recombination events among variants. Subgenomic sequencing, while historically common in viral studies, has been less frequently utilized during MERS-CoV research.",
      "retrieved_chunks": [
        "Title: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Most of the analysis of MERS-CoV genetics has been performed using high throughput or \"deep\" sequencing methods for complete genome deduction . MERS-CoV was the first subject of such widespread use of deep sequencing to study an emerging viral outbreak with global reach. The technique can produce genomic . Earlier and subsequent versions of this chart are maintained on a personal blog length coverage in a single experiment with highly repetitious measurement of each nucleotide position . Despite assays having been published early on, subgenomic sequencing, once the mainstay of viral outbreak studies, has less often been published during MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Analyses of MERS-CoV genomes have shown that most single nucleotide differences among variants were located in the last third of the genome , which encodes the spike protein and accessory proteins .",
        "The spike protein had not changed in the recombinant MERS-CoV genome identified in China in 2015 but was reported to have varied at a higher rate than that for complete MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Vigilance remains important for containment since MERS-CoV is a virus with a genetic makeup that has been observed for only three years and is not stable. Among all humans reported to be infected, nearly 40 % have died. Continued laboratory testing, sequencing, analysis, timely data sharing and clear communication are essential for such vigilance to be effective. Global alignment of case definitions would further aid accurate calculation of a case fatality ratio by including subclinical case numbers. Whole genome sequencing has been used extensively to study MERS-CoV travel and variation and although it remains a tool for experts, it appears\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Two studies during 2015, one looking at Jeddah-2014 MERS-CoV variants and another looking at a variant exported from South Korea to China, have now identified signs of genetic recombination among MERS-CoV variants.",
        "Global alignment of case definitions would further aid accurate calculation of a case fatality ratio by including subclinical case numbers. Whole genome sequencing has been used extensively to study MERS-CoV travel and variation and although it remains a tool for experts, it appears\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Two studies during 2015, one looking at Jeddah-2014 MERS-CoV variants and another looking at a variant exported from South Korea to China, have now identified signs of genetic recombination among MERS-CoV variants. While human and camel whole genome sequences have retained >99 % identity with each other, members of genetically distinct lineages can and do swap genetic material when suitable conditions and coinfections co-occur . Shared identity implies that the major source for human acquisition is the DC, rather than another animal, although more testing of other animal species is needed to confirm that conclusion. Over a month, a DC",
        "Earlier and subsequent versions of this chart are maintained on a personal blog length coverage in a single experiment with highly repetitious measurement of each nucleotide position . Despite assays having been published early on, subgenomic sequencing, once the mainstay of viral outbreak studies, has less often been published during MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Analyses of MERS-CoV genomes have shown that most single nucleotide differences among variants were located in the last third of the genome , which encodes the spike protein and accessory proteins . At least nine MERS-CoV genomes contained amino acid substitutions in the receptor binding domain of the spike protein and codons 158 , 460 , 1020 , 1202 and 1208 bear investigation as markers of adaptive change . The spike protein had not changed in the recombinant MERS-CoV genome identified in China in 2015 but was reported to have varied at a higher rate than that for complete MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Vigilance remains important for containment since MERS-CoV is a virus with a genetic makeup that has been observed for only three years and is not stable. Among all humans reported to be infected, nearly 40 % have died."
      ],
      "computed_relevance": 0.05,
      "computed_utilization": 0.05,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2857142857142857,
      "gt_utilization": 0.047619047619047616,
      "gt_completeness": 0.16666666666666666,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 8,
      "dataset_id": "1129",
      "question": "How were  the spread of GFP-expressing virus-infected cells tracked?",
      "ground_truth_answer": "The spread of GFP-expressing virus-infected cells was tracked using immunofluorescence microscopy, whole-organ imaging with IVIS, flow cytometry, and inverted fluorescence microscopy.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how the spread of GFP-expressing virus-infected cells was tracked. I need to look through the provided contexts to find the relevant information.\n\nFirst, I'll go through each passage. The first context mentions using a split-GFP-tagged viral protein to illuminate replication sites. They used transduction and puromycin selection for stable GFP expression. But this seems more about generating cells that express GFP, not tracking spread.\n\nThe second context, \"Accelerated viral dynamics in bat cell lines...\" talks about monitoring plates with an inverted fluorescence microscope until GFP expression is seen. Then they use a CellInsight CX5 platform with a 4X objective. They image a subset of each well periodically. The settings are standardized, with fixed exposure time. Images show GFP cells in white and others in black. This seems like a method to track GFP expression over time in cell cultures.\n\nThird context is similar to the second, mentioning the same microscope settings. The fourth context discusses in vivo imaging using multi-photon microscopy with fluorescent proteins like EGFP and mCherry. They mention long-term tracking due to strong expression and good signal-to-noise ratio. This would allow tracking in live animals, maybe in tissues.\n\nThe fifth context is about influenza viruses with reporter genes. They used IVIS for whole-organ imaging of lungs ex vivo and flow cytometry to analyze infection progression in antigen-presenting cells. They observed infection starting near airways and spreading deeper. Also, percentages of GFP+ cells in different immune cells at 48h post-infection.\n\nPutting this together, the tracking methods include fluorescence microscopy (inverted and high-content screening platforms) for in vitro studies, multi-photon intravital microscopy for in vivo tracking, IVIS for whole-organ imaging, and flow cytometry for analyzing specific cell populations. The answer should list these methods as the ways the spread was tracked.\n</think>\n\nThe spread of GFP-expressing virus-infected cells was tracked using multiple imaging techniques:  \n1. **Fluorescence microscopy** (inverted fluorescence microscope and CellInsight CX5 High Content Screening Platform) to monitor GFP expression in cell cultures over time, with standardized settings for consistent imaging.  \n2. **Multi-photon intravital microscopy** for in vivo visualization of fluorescent proteins (e.g., EGFP, mCherry) in live animals, enabling long-term tracking of dividing cells and small structures",
      "retrieved_chunks": [
        "Title: Illuminating the Sites of Enterovirus Replication in Living Cells by Using a Split-GFP-Tagged Viral Protein\nPassage: transduction, the MLV particles were 5 to 10 times concentrated using a 100-kDa concentrator . For the generation of single-cell clones stably expressing GFP, BGM and HeLa cells were transduced and grown in the presence of puromycin to generate pools of GFP-expressing cells, which were subsequently used to prepare single-cell clones by limiting dilution. Expression of GFP was monitored during passaging by immunofluorescence microscopy using the GFP antibody. Title: Accelerated viral dynamics in bat cell lines, with implications for zoonotic emergence\nPassage: After application of the overlay, plates were monitored periodically using an inverted fluorescence microscope until the first signs of GFP expression were witnessed . From that time forward, a square subset of the center of each well was imaged periodically, using a CellInsight CX5 High Content Screening Platform with a 4X air objective .",
        "Title: Accelerated viral dynamics in bat cell lines, with implications for zoonotic emergence\nPassage: After application of the overlay, plates were monitored periodically using an inverted fluorescence microscope until the first signs of GFP expression were witnessed . From that time forward, a square subset of the center of each well was imaged periodically, using a CellInsight CX5 High Content Screening Platform with a 4X air objective . Microscope settings were held standard across all trials, with exposure time fixed at 0.0006 s for each image. One color channel was imaged, such that images produced show GFP-expressing cells in white and non-GFP-expressing cells in black . Title: Visualizing Viral Infection In Vivo by Multi-Photon Intravital Microscopy\nPassage: express cytoplasmic fluorescent proteins driven e.g., by the chicken \u03b2-actin promoter with cytomegalovirus enhancer or human ubiquitin C promoter .",
        "One color channel was imaged, such that images produced show GFP-expressing cells in white and non-GFP-expressing cells in black . Title: Visualizing Viral Infection In Vivo by Multi-Photon Intravital Microscopy\nPassage: express cytoplasmic fluorescent proteins driven e.g., by the chicken \u03b2-actin promoter with cytomegalovirus enhancer or human ubiquitin C promoter . Many different mouse lines are available that contain reporter genes for cytoplasmic fluorescent proteins such as EGFP and mCherry . Due to strong and continuous expression rate of the fluorescent proteins long-term tracking of dividing cells without extensive bleaching is possible. In addition, with a superior signal-to-noise ratio visualization of small cellular structures with low cytoplasm content is feasible.",
        "Due to strong and continuous expression rate of the fluorescent proteins long-term tracking of dividing cells without extensive bleaching is possible. In addition, with a superior signal-to-noise ratio visualization of small cellular structures with low cytoplasm content is feasible. Although the approach to adoptively transfer fluorescent cells of interest into donor mice for functional imaging studies is fast and flexible,\n\nTitle: Replication-Competent Influenza A Viruses Expressing Reporter Genes\nPassage: lungs. Not only was GFP observable in the lungs of infected mice ex vivo using IVIS for whole-organ imaging, but could also be observed using flow cytometry to analyze the infection progression in antigen presenting cells . Imaging of murine lungs showed that infection starts in the respiratory tract in areas close to large conducting airways and later spreads to deeper sections of the lungs .",
        "Not only was GFP observable in the lungs of infected mice ex vivo using IVIS for whole-organ imaging, but could also be observed using flow cytometry to analyze the infection progression in antigen presenting cells . Imaging of murine lungs showed that infection starts in the respiratory tract in areas close to large conducting airways and later spreads to deeper sections of the lungs . The authors found that using a 10 6 PFU intranasal inoculation, 10% of dendritic cells were observed to express GFP and 2%-3% of macrophages and neutrophils were also GFP+ at 48 h post-infection ."
      ],
      "computed_relevance": 0.4782608695652174,
      "computed_utilization": 0.6521739130434783,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.21052631578947367,
      "gt_utilization": 0.21052631578947367,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 9,
      "dataset_id": "1261",
      "question": "What's the recommended procedure to disinfect at CT scanner after a COVID-19 exposure?",
      "ground_truth_answer": "The recommended procedure to disinfect a CT scanner after a COVID-19 exposure involves sterilization procedures, noncontaminated CT disinfection procedures, and immediate disinfection of the imaging equipment after the examination.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about the recommended procedure to disinfect a CT scanner after a COVID-19 exposure. The context provided has several passages related to CT disinfection procedures. \n\nFirst, I need to look through the given context. The titles all mention emergency management related to COVID-19. The passages mention \"Noncontaminated CT disinfection procedures after suspected COVID-19 case examination\" and \"Fever-CT disinfection procedures after examination.\" There's also a part about preparing to disinfect the imaging equipment immediately after the examination.\n\nThe key points here are that after examining a suspected COVID-19 case, the CT equipment needs to be disinfected. The procedures are referred to as \"Noncontaminated CT disinfection\" and \"Fever-CT disinfection.\" The passage also mentions that the equipment is prepared for disinfection immediately after the exam. \n\nSince the question is about the recommended procedure, the answer should include the steps or the method they use. However, the provided context doesn't go into specific details like the type of disinfectant or the exact steps. It just mentions that the procedures are carried out immediately after the examination. \n\nWait, but the titles and passages are a bit repetitive. The first passage mentions \"Noncontaminated CT disinfection procedures,\" which might imply that they follow specific protocols to ensure the CT is disinfected properly. The other mentions \"Fever-CTs\" which could be a specific type of CT used for fever cases. \n\nSince the context doesn't provide detailed steps, the answer should probably be based on the information given. The answer would be that the recommended procedure is to disinfect the CT scanner immediately after the examination using the established protocols for noncontaminated or fever-CTs. But since the exact steps aren't detailed, the answer should reflect that the procedure involves immediate disinfection after the exam as part of emergency management for COVID-19.\n</think>\n\nThe recommended procedure to disinfect a CT scanner after a COVID-19 exposure involves **immediately disinfecting the imaging equipment following the examination** using established protocols. The context emphasizes that noncontaminated CT and fever-CT disinfection procedures are implemented promptly after suspected or confirmed COVID-19 cases to ensure safety. While specific steps (e.g., disinfectants or duration) are not detailed in the provided passages, the key action is the immediate post",
      "retrieved_chunks": [
        "Title: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: Noncontaminated CT disinfection procedures after suspected COVID-19 case examination\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: Fever-CT disinfection procedures after examination\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: fever-CTs) after these sterilization procedures. Title: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: equipment and prepares to disinfect the imaging equipment immediately after the examination."
      ],
      "computed_relevance": 1.0,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.5,
      "gt_utilization": 0.5,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    }
  ],
  "skipped_samples": []
}